Taken together, our findings offer fresh insights for further elucidating the pathogenesis in MDA5+ DM with RP-ILD and provide valuable clues for developing promising therapeutic and prognostic biomarkers. This evidence concerns the gene IFIH1 and interstitial lung disease.